OLD Second National Bank of Aurora Boosts Holdings in Stryker Co. (NYSE:SYK)

OLD Second National Bank of Aurora grew its holdings in shares of Stryker Co. (NYSE:SYK) by 0.9% during the 4th quarter, HoldingsChannel reports. The fund owned 8,188 shares of the medical technology company’s stock after acquiring an additional 75 shares during the quarter. OLD Second National Bank of Aurora’s holdings in Stryker were worth $2,452,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in SYK. Peterson Wealth Services increased its stake in shares of Stryker by 2.2% in the fourth quarter. Peterson Wealth Services now owns 12,098 shares of the medical technology company’s stock worth $3,623,000 after buying an additional 255 shares during the period. Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Stryker by 3.0% during the 4th quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 10,979 shares of the medical technology company’s stock valued at $3,295,000 after purchasing an additional 322 shares during the last quarter. Daiwa Securities Group Inc. increased its position in shares of Stryker by 7.8% during the 4th quarter. Daiwa Securities Group Inc. now owns 34,107 shares of the medical technology company’s stock valued at $10,214,000 after purchasing an additional 2,468 shares during the last quarter. Oakworth Capital Inc. increased its position in shares of Stryker by 1.7% during the 4th quarter. Oakworth Capital Inc. now owns 5,908 shares of the medical technology company’s stock valued at $1,769,000 after purchasing an additional 100 shares during the last quarter. Finally, Tyche Wealth Partners LLC purchased a new stake in shares of Stryker during the 4th quarter valued at about $417,000. 77.09% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms recently issued reports on SYK. Canaccord Genuity Group raised shares of Stryker from a “hold” rating to a “buy” rating and set a $360.00 target price for the company in a report on Wednesday, January 31st. Truist Financial increased their target price on shares of Stryker from $330.00 to $345.00 and gave the stock a “hold” rating in a report on Wednesday, January 31st. Canaccord Genuity Group upgraded Stryker from a “hold” rating to a “buy” rating and upped their price target for the stock from $315.00 to $360.00 in a research note on Wednesday, January 31st. Evercore ISI increased their target price on Stryker from $340.00 to $370.00 and gave the company an “outperform” rating in a research report on Thursday, April 4th. Finally, StockNews.com upgraded Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, January 23rd. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $340.45.

Stryker Stock Performance

SYK stock traded down $2.52 during trading on Thursday, hitting $333.51. 469,792 shares of the company traded hands, compared to its average volume of 1,241,465. The stock’s 50-day simple moving average is $350.57 and its 200 day simple moving average is $312.03. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.58 and a quick ratio of 0.97. The company has a market cap of $126.89 billion, a PE ratio of 40.73, a P/E/G ratio of 2.72 and a beta of 0.89. Stryker Co. has a 1 year low of $249.98 and a 1 year high of $361.41.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Tuesday, January 30th. The medical technology company reported $3.46 earnings per share for the quarter, beating the consensus estimate of $3.27 by $0.19. The company had revenue of $5.82 billion during the quarter, compared to analysts’ expectations of $5.60 billion. Stryker had a return on equity of 22.99% and a net margin of 15.44%. Stryker’s quarterly revenue was up 11.8% on a year-over-year basis. During the same period last year, the business earned $3.00 earnings per share. On average, equities analysts expect that Stryker Co. will post 11.86 earnings per share for the current fiscal year.

Stryker Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be given a dividend of $0.80 per share. This represents a $3.20 annualized dividend and a dividend yield of 0.96%. The ex-dividend date of this dividend is Wednesday, March 27th. Stryker’s payout ratio is 38.79%.

Insider Buying and Selling

In related news, Director Allan C. Golston sold 3,273 shares of the business’s stock in a transaction that occurred on Friday, February 2nd. The stock was sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the completion of the sale, the director now directly owns 14,242 shares in the company, valued at $4,856,522. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Stryker news, Director Allan C. Golston sold 3,273 shares of the business’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $341.00, for a total transaction of $1,116,093.00. Following the transaction, the director now owns 14,242 shares of the company’s stock, valued at $4,856,522. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Ronda E. Stryker sold 201,146 shares of the business’s stock in a transaction on Monday, February 5th. The stock was sold at an average price of $342.90, for a total value of $68,972,963.40. Following the transaction, the director now directly owns 3,755,128 shares in the company, valued at approximately $1,287,633,391.20. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 212,109 shares of company stock worth $72,845,768. 5.90% of the stock is owned by corporate insiders.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.